10019-0080 Eribulin Mesylate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

10019-0080

Brand Name:

Eribulin Mesylate

Generic Name:

Eribulin Mesylate

Dosage Form Name:

INJECTION

Administration Route:

Intravenous

Substances:

Name: ERIBULIN MESYLATE

Strength: 0.5

Unit: mg/mL

Packages:

Code: 10019-0080-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Dec. 1, 2024

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Antimitotic Agent

Minor Class:

Furopyrans

Orphan Drug Designation:

Status:

In Use